Canada markets open in 3 hours 16 minutes

G1 Therapeutics, Inc. (GTHX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.2900+0.0400 (+0.94%)
At close: 04:00PM EDT
4.2900 0.00 (0.00%)
After hours: 05:58PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 224.29M
Enterprise Value 206.19M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.65
Price/Book (mrq)8.09
Enterprise Value/Revenue 2.45
Enterprise Value/EBITDA -11.42

Trading Information

Stock Price History

Beta (5Y Monthly) 1.71
52-Week Change 353.76%
S&P500 52-Week Change 325.59%
52 Week High 35.0000
52 Week Low 31.0800
50-Day Moving Average 34.0172
200-Day Moving Average 32.6860

Share Statistics

Avg Vol (3 month) 31.13M
Avg Vol (10 day) 3593.16k
Shares Outstanding 552.28M
Implied Shares Outstanding 652.28M
Float 843.93M
% Held by Insiders 110.81%
% Held by Institutions 128.87%
Shares Short (Apr 15, 2024) 42.42M
Short Ratio (Apr 15, 2024) 42.73
Short % of Float (Apr 15, 2024) 44.67%
Short % of Shares Outstanding (Apr 15, 2024) 44.63%
Shares Short (prior month Mar 15, 2024) 42.69M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -36.40%
Operating Margin (ttm)-62.50%

Management Effectiveness

Return on Assets (ttm)-10.81%
Return on Equity (ttm)-84.13%

Income Statement

Revenue (ttm)84.04M
Revenue Per Share (ttm)1.62
Quarterly Revenue Growth (yoy)11.80%
Gross Profit (ttm)N/A
EBITDA -22.33M
Net Income Avi to Common (ttm)-30.59M
Diluted EPS (ttm)-0.6000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)65.19M
Total Cash Per Share (mrq)1.25
Total Debt (mrq)47.09M
Total Debt/Equity (mrq)169.76%
Current Ratio (mrq)2.94
Book Value Per Share (mrq)0.53

Cash Flow Statement

Operating Cash Flow (ttm)-18.18M
Levered Free Cash Flow (ttm)-4.94M